Literature DB >> 1580271

Urinary tract infections.

H C Neu1.   

Abstract

The populations at risk for urinary tract infection include the newborn, particularly the premature, prepubertal girls, young boys, sexually active young women, elderly males, and elderly females. Risk factors that contribute to lower tract infection in women include sexual intercourse, diaphragm-spermicide use, and voiding behavior. Host factors, more than bacterial virulence, are probably the most important contributors to infection. The genetic factors that are important contributors are secretor status and P blood group phenotype. Which patients to culture, when to culture, and the number of organisms required to define infection have changed in the past decade. A concentration of 10(2) colony forming units/mL can cause an acute urinary tract infection in the healthy woman. The presence of leukocytes in the urine is of increasing diagnostic importance. Complicated urinary tract infections occur in neonates with such congenital anomalies of the urinary tract as urethral valves or in patients with neurologic disease resulting in urinary stasis. In older men or women, complicated urinary tract infections occur with obstruction, instrumentation, surgery, anatomic abnormalities, or stones. Single-dose therapy of uncomplicated urinary tract infection is useful in only a small subset of patients, specifically in patients less than 45 years of age who have short duration of symptoms. The majority of patients with uncomplicated infections should receive treatment for 3-5 days. Response to therapy and long-term cure rates in complicated urinary tract infection are related both to the type of underlying abnormality and to the species of the infecting organism. Complicated urinary tract infections should be treated for 7-14 days.

Entities:  

Mesh:

Year:  1992        PMID: 1580271     DOI: 10.1016/0002-9343(92)90312-y

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Prescription data as a tool in pharmacotherapy audit (I). General considerations.

Authors:  C S de Vries; T F Tromp; W Blijleven; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

Review 2.  Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.

Authors:  T Lipman; D Price
Journal:  BMJ       Date:  2000-04-22

3.  Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Authors:  W J Hopkins; A Gendron-Fitzpatrick; E Balish; D T Uehling
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence.

Authors:  N Rajan; Q Cao; B E Anderson; D L Pruden; J Sensibar; J L Duncan; A J Schaeffer
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991-1995.

Authors:  G Weber; K Riesenberg; F Schlaeffer; N Peled; A Borer; P Yagupsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

6.  Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.

Authors:  K E Rippere-Lampe; A D O'Brien; R Conran; H A Lockman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis.

Authors:  Georgios Christopoulos; V Christopoulou; J G Routsias; A Babionitakis; C Antoniadis; G Vaiopoulos
Journal:  Clin Rheumatol       Date:  2016-10-08       Impact factor: 2.980

8.  Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Gaza Strip, Palestine.

Authors:  Zakaria El Astal
Journal:  J Biomed Biotechnol       Date:  2005
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.